GDF15 and ACE2 stratify COVID19 patients according to severity while ACE2 mutations increase infection susceptibility.
Margalida Torrens‐Mas, Catalina M. Perelló-Reus, Neus Trias-Ferrer, Lesly Ibargüen-González, Catalina Crespı́, Aina Maria Galmes-Panades, Cayetano Navas-Enamorado, Andrés Sánchez-Polo, Javier Pierola Lopetegui, Lluís Masmiquel, Lorenzo Socías Crespí, Carles Barceló, Marta González‐Freire
This study finds that GDF15 and ACE2 levels in plasma stratify COVID-19 patients by severity, and ACE2 SNPs are linked to increased infection susceptibility.
Frontiers in Cellular and Infection Microbiology · Jul 22, 2022Peer-reviewedMolecular Biology